, Phase 1 studies evaluated safety, tolerability, and pharmacokinetic characteristics Early data from Phase 2 investigations provided insights into biological activity and physiological responses
(5.8) Adverse Reactions/Side Effects Adverse reactions have included anaphylaxis, rash, erythema, pruritus, headache, dizziness, agitation, anxiety, diplopia
Responses of gut microbiota to diet composition and weight loss in lean and obese mice (in Eng)
Temporary pain, swelling, stiffness or bruising can occur after treatment
demonstrated direct in vivo monitoring of nitric oxide (NO) shows that relatively short lasting inflammatory processes of the paw are correlated with a spinal increase in NO production
Higher morning HRV generally correlates with better restorative sleep